Search results for " RATIO"

showing 10 items of 3859 documents

Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study

2010

Standard treatment of patients with breast cancer decreases with age and older persons are mostly excluded from clinical trials. We hypothesized that non-adherence to treatment guidelines occurs for women agedor =70 years and changes overall survival (OAS) and disease-free survival (DFS).We enrolled 1922 women agedor =50 years with histologically confirmed invasive breast cancer treated at the University of Ulm from 1992 to 2005. Adherence to guidelines and effects on OAS and DFS for women agedor =70 years was compared with that for younger women (50-69 years).Women70 years less often received recommended breast-conserving therapy (70-79 years: 74%-83%;79 years: 54%) than women agedor =69 y…

medicine.medical_specialtyBreast NeoplasmsMedical OncologyCohort StudiesBreast cancerGermanyInternal medicinemedicineHumansMastectomySurvival analysisAgedAged 80 and overGynecologyRadiotherapybusiness.industryStandard treatmentCarcinomaHazard ratioAge FactorsCancerProfessional PracticeHematologyMiddle Agedmedicine.diseaseSurvival AnalysisChemotherapy regimenOncologyChemotherapy AdjuvantFemaleGuideline AdherenceBreast diseasebusinessCohort studyAnnals of Oncology
researchProduct

Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: A systematic review

2013

AIM: To investigate potential therapeutic recommendations for endoscopic and surgical resection of T1a/T1b esophageal neoplasms. METHODS: A thorough search of electronic databases MEDLINE, Embase, Pubmed and Cochrane Library, from 1997 up to January 2011 was performed. An analysis was carried out, pooling the effects of outcomes of 4241 patients enrolled in 80 retrospective studies. For comparisons across studies, each reporting on only one endoscopic method, we used a random effects meta-regression of the log-odds of the outcome of treatment in each study. “Neural networks” as a data mining technique was employed in order to establish a prediction model of lymph node status in superficial …

medicine.medical_specialtyBrief ArticleEsophageal NeoplasmsLymphovascular invasionEndoscopic mucosal resectionRisk AssessmentRisk FactorsmedicineCarcinomaOdds RatioHumansNeoplasm InvasivenessLymph nodeNeoplasm Stagingbusiness.industryCarcinoma in situPatient SelectionCarcinomaGastroenterologyGeneral MedicineEsophageal cancermedicine.diseaseSurgerySquamous carcinomaEsophagectomymedicine.anatomical_structureTreatment OutcomeLymphatic MetastasisAdenocarcinomaRadiologyEsophagoscopyNeoplasm GradingNeoplasm Recurrence Localbusiness
researchProduct

The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent exacerbation history

2019

Background: Patients with COPD with a history of frequent exacerbations are at increased risk of future exacerbations. There are limited data as to whether combining LAMA/LABA reduces exacerbation risk in all patients. We investigated whether tiotropium/olodaterol (T/O) reduced exacerbation rate versus tiotropium (tio) in patients with a range of exacerbation histories. Methods: TONADO 1+2 (NCT01431274/NCT01431287) and DYNAGITO (NCT02296138) were 52-week, parallel-group, randomised, double-blind, Phase III trials in COPD patients with FEV1 Results: There was a lower rate of moderate/severe exacerbations with T/O (0.68 per patient-year) than tio (0.77 per patient-year) (rate ratio [RR] vs ti…

medicine.medical_specialtyCOPDExacerbationbiologybusiness.industryOlodateroltechnology industry and agricultureTiotropium-olodaterolLamaRate ratiobiology.organism_classificationmedicine.disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicine030228 respiratory systemchemistryCopd exacerbationInternal medicinemedicineIn patient030212 general & internal medicinebusinessMonitoring airway disease
researchProduct

Determining SGRQ and TDI responder rates across the duration of clinical trials: Results from tiotropium + olodaterol in COPD

2017

Introduction: Patient-reported outcomes (PROs) are important in COPD for understanding patients’ symptoms and experience of the disease. Responder rates at specific timepoints are frequently used to analyse clinically important improvements in PROs. Alternatively, responders can be defined using average PRO improvement vs. baseline over the whole study period or the last two timepoints, as recently discussed by the FDA. Aims and objectives: To compare three techniques for determining responder rates of St. George’s Respiratory Questionnaire (SGRQ) and transition dyspnoea index (TDI). Methods: Two double-blind, replicate, Phase III, 52-week TONADO trials compared tiotropium + olodaterol (T+O…

medicine.medical_specialtyCOPDbusiness.industryOlodaterolArea under the curveTiotropium-olodaterolOdds ratiomedicine.diseaseClinical trialchemistry.chemical_compoundchemistryInternal medicineMedicinebusinessClinical Problems COPD
researchProduct

0329 Occupational exposure to metals and welding fumes, and risk of glioma in the interocc study

2017

Background Brain tumouraetiology is poorly understood. Based on their ability to pass through the blood-brain barrier, it has been hypothesised that exposure to metals may increase the risk of brain cancer. Results from the few epidemiological studies on this issue are inconsistent. Methods We investigated the relationship between glioma risk and occupational exposure to five metals - lead, cadmium, nickel, chromium and iron- as well as to welding fumes, using data from the seven-country INTEROCC study. A total of 1800 incident glioma cases and 5160 controls aged 30–69 years were included in the analysis. Lifetime occupational exposure to the agents was assessed using the INTEROCC JEM, a mo…

medicine.medical_specialtyCadmiumbusiness.industryJob-exposure matrixchemistry.chemical_elementCumulative ExposureOdds ratioLogistic regressionmedicine.diseaseConfidence intervalchemistryEnvironmental healthGliomaEpidemiologymedicinebusinessOral Presentation
researchProduct

Oral Lichen Planus : risk factors of malignant transformation and follow up. Ten years retrospective study

2020

Background Oral Lichen Planus (OLP) is an inflammatory chronic disease. Modified World Health Organization (WHO) diagnostic criteria (2003) suggest diagnosing OLP both clinically and histologically. Furthermore, it is known the potential of malignant transformation of OLP, especially those affecting mucosa. Aims of this retrospective study on 100 patients were i) to estimate the timing of transformation of OLP lesions in OSCC in a cohort of patients observed between 2008 and 2018; ii) to assess risk factors of OLP patients diagnosed with OSCC; iii) to analyse forms of OLP evolved in cancer. Material and methods A database of 100 patients diagnosed with OLP was evaluated and clinical, histol…

medicine.medical_specialtyCancer preventionOral Medicine and Pathologybusiness.industryResearchCancerRetrospective cohort studyOdds ratiomedicine.diseaseDermatologyOral Lichen Planus Oral Cancer Malignant transformation risk factorsWorld healthMalignant transformationstomatognathic diseasesstomatognathic systemMalignant transformationCohortmedicineOral Cancerrisk factorsOral lichen planusOral Lichen PlanusbusinessGeneral DentistryUNESCO:CIENCIAS MÉDICAS
researchProduct

Utilization of professional psychological care in a large German sample of cancer patients

2016

Objective Although one-third of cancer patients are perceived to have a need for psychological support based on the percentage of mental disorders, little is known about the actual utilization of psychological care in cancer. We aimed to assess cancer patients' reported use of psychological care and its correlates in a large, representative sample. Methods In a multicenter, cross-sectional study in Germany, 4020 cancer patients (mean age 58 years, 51% women) were evaluated. We obtained self-reports of use of psychotherapy and psychological counseling. We measured distress with the Distress Thermometer, symptoms of depression with the Patient Health Questionnaire, anxiety with the Generalize…

medicine.medical_specialtyCancerExperimental and Cognitive PsychologyOdds ratiomedicine.diseaseConfidence intervalPatient Health Questionnaire03 medical and health sciencesPsychiatry and Mental healthDistressSocial support0302 clinical medicineOncology030220 oncology & carcinogenesismedicineAnxiety030212 general & internal medicinemedicine.symptomPsychologyPsychiatryDepression (differential diagnoses)Clinical psychologyPsycho-Oncology
researchProduct

Large-Scale Candidate Gene Analysis in Whites and African Americans Identifies IL6R Polymorphism in Relation to Atrial Fibrillation The National Hear…

2011

Background— The genetic background of atrial fibrillation (AF) in whites and African Americans is largely unknown. Genes in cardiovascular pathways have not been systematically investigated. Methods and Results— We examined a panel of approximately 50 000 common single-nucleotide polymorphisms (SNPs) in 2095 cardiovascular candidate genes and AF in 3 cohorts with participants of European (n=18 524; 2260 cases) or African American descent (n=3662; 263 cases) in the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource. Results in whites were followed up in the German Competence Network for AF (n=906, 468 cases). The top result was assessed in relation to incident i…

medicine.medical_specialtyCandidate geneINTERLEUKIN-6ATHEROSCLEROSIS RISKSingle-nucleotide polymorphismVARIANTSDISEASEINFLAMMATIONDESIGNsingle nucleotide polymorphismInternal medicinecohort studyGeneticsmedicineatrial fibrillationCHROMOSOME 4Q25Genetics (clinical)Geneticsbusiness.industryHazard ratioAtrial fibrillationrace/ethnicitymedicine.diseaseC-REACTIVE PROTEINEUROPEAN ANCESTRYISCHEMIC-STROKERelative riskCohortepidemiologyCardiology and Cardiovascular MedicinebusinessCandidate Gene AnalysisCohort study
researchProduct

Expert opinion on managing chronic HCV in patients with cardiovascular disease

2018

International audience; Extrahepatic manifestations of chronic HCV infection include cardiovascular diseases and an increase in cardiovascular mortality. The pathogenic mechanisms by which HCV contributes to cardiovascular disease are not well defined, however, it is likely that systemic inflammation, and the promotion of other metabolic diseases are involved. In this Review, the evidence for HCV infection as a non-traditional risk factor for cardiovascular disease is evaluated. Furthermore, practical advice to evaluate cardiovascular disease risk and disease in chronic hepatitis C patients are included for help in daily clinical practice. Despite the advances in therapies for the treatment…

medicine.medical_specialtyCardiotonic AgentsHepacivirusDisease030204 cardiovascular system & hematologySystemic inflammationAntiviral Agents03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemRisk Factors[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesOdds RatioHumansMedicineDrug InteractionsPharmacology (medical)In patient030212 general & internal medicineRisk factorIntensive care medicineExpert TestimonyCardiovascular mortalityInflammationPharmacologybusiness.industryDisease progressionDisease ManagementHepatitis C Chronic3. Good healthInfectious DiseasesCardiovascular DiseasesExpert opinionPractice Guidelines as TopicDisease riskmedicine.symptombusiness
researchProduct

Osteoarthritis and mortality: a prospective cohort study and systematic review with meta-analysis

2016

Objectives: Osteoarthritis (OA) is a leading cause of disability, but the relationship with premature mortality remains uncertain. We aimed to investigate the relationship between OA and mortality from any cause and from cardiovascular disease (CVD).\ud \ud Methods: Electronic literature databases searches were conducted to identify prospective studies comparing mortality in a sample of people with and without OA. Risk of all-cause and CVD mortality were summarized using adjusted hazard ratios (HRs) for joint specific (hand, hip, and knee) and joint non-specific OA. New data from the Progetto Veneto Anziani (PRO.V.A.) study were also included. Results: From the PRO.V.A. study (N 1⁄4 2927), …

medicine.medical_specialtyCardiovascular disease; Mortality; Osteoarthritis; Rheumatology; Anesthesiology and Pain MedicineOsteoarthritisDiseaseComorbidity03 medical and health sciences0302 clinical medicineRheumatologycardiovascular diseaseRisk FactorsInternal medicineOsteoarthritismedicineHumans030212 general & internal medicineProspective StudiesMortalityProspective cohort study030203 arthritis & rheumatologybusiness.industryHazard ratioOsteoarthritis Mortality Cardiovascular diseasemedicine.diseaseCardiovascular diseaseR1ComorbiditymortalityRheumatologyosteoarthritisIncreased riskAnesthesiology and Pain MedicineCardiovascular DiseasesMeta-analysisPhysical therapybusinessCardiovascular disease; Mortality; Osteoarthritis
researchProduct